A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Clinical trial NCT07497087 · RECRUITING

Trial details

NCT number: NCT07497087
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2026-07-27
Primary completion: 2030-02-26
Enrollment: 448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.